2024
article
OpenAlex
Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini, Aneel A. Ashrani et autres
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary …
us, in, Afrique du Sud
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Sherri Huang, Aryanna Jordan, Dakota Jenneman, Michael Shafique et autres
Immune checkpoint inhibitors (ICIs) are important novel agents used in advanced non-small cell lung cancer (NSCLC) standard regimens; however, their use increases the risk of immune-related adverse effects (IRAEs). The incidence of IRAE pneumonitis is well documented in ICI use. Corticosteroids continue …
us
(code pays fourni par la source)
2021
article
OpenAlex
Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini, Aneel A. Ashrani et autres
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of patients with cancer who have developed or who are at risk for developing venous thromboembolism (VTE). VTE is a significant concern …
us, in
(code pays fourni par la source)
2021
article
OpenAlex
Kieun Seok, Julie Hallanger‐Johnson, Bjorn Holmstrom, Timothy N. Hembree et autres
us
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini, Aneel A. Ashrani et autres
Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in …
us, Afrique du Sud
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Ateefa Chaudhury, Asha Balakrishnan, Christy Thai, Bjorn Holmstrom et autres
us
(code pays fourni par la source)
2016
article
OpenAlex
Ateefa Chaudhury, Asha Balakrishnan, Christy Thai, Bjorn Holmstrom et autres
Abstract BACKGROUND: Venous thromboembolism is a well-known complication of malignancy. The Khorana Risk Score (KRS) utilizes the type of cancer, blood counts, and body mass index to predict risk of thrombosis in cancer patients. Patients with a KRS of greater than 3 …
us
(code pays fourni par la source)
2015
article
OpenAlex
Ateefa Chaudhury, Asha Balakrishnan, Christy Thai, Bjorn Holmstrom et autres
Abstract Introduction: Venous thromboembolism (VTE) in the form of deep venous thrombosis (DVT) or pulmonary embolism (PE) is a complication of malignancy. Several studies have demonstrated the superiority of dalteparin (Fragmin®), a low molecular weight heparin (LMWH), in comparison to oral vitamin …
us
(code pays fourni par la source)
2015
article
OpenAlex
Michael B. Streiff, Bjorn Holmstrom, Aneel A. Ashrani, Paula Bockenstedt et autres
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of venous thromboembolism (VTE) in adult patients with a diagnosis of cancer or for whom cancer is clinically suspected. VTE is a common complication in patients with cancer, …
us, be, de, in, kr, jp
(code pays fourni par la source)
Accès ouvert
2011
article
OpenAlex
Michael B. Streiff, Paula Bockenstedt, Spero R. Cataland, C Chesney et autres
Venous thromboembolism (VTE) remains a common and life-threatening complication among patients with cancer. Thromboprophylaxis can be used to prevent the occurrence of VTE in patients with cancer who are considered at high risk for developing this complication. Therefore, it is critical to …
us, in
(code pays fourni par la source)
2011
article
OpenAlex
Thomas L. Ortel, Judy L. Smith, Gary C. Yee, Anaadriana Zakarija et autres